ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 118 filers reported holding ARENA PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.65 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $47,000 | -54.4% | 32,085 | -55.6% | 0.00% | – |
| Q4 2016 | $103,000 | +87.3% | 72,238 | +133.8% | 0.00% | – |
| Q3 2016 | $55,000 | +2650.0% | 30,893 | +3359.5% | 0.00% | – |
| Q2 2016 | $2,000 | -96.7% | 893 | -97.1% | 0.00% | – |
| Q1 2016 | $61,000 | +7.0% | 30,893 | +2.7% | 0.00% | – |
| Q4 2015 | $57,000 | -16.2% | 30,073 | -16.5% | 0.00% | – |
| Q3 2015 | $68,000 | -64.2% | 35,998 | -12.4% | 0.00% | – |
| Q2 2015 | $190,000 | +7.3% | 41,096 | +1.3% | 0.00% | – |
| Q1 2015 | $177,000 | +22.9% | 40,586 | -2.4% | 0.00% | – |
| Q4 2014 | $144,000 | +6.7% | 41,592 | +28.9% | 0.00% | – |
| Q3 2014 | $135,000 | -28.6% | 32,256 | -0.1% | 0.00% | – |
| Q2 2014 | $189,000 | -6.9% | 32,276 | +0.0% | 0.00% | – |
| Q1 2014 | $203,000 | -42.2% | 32,275 | -46.2% | 0.00% | -100.0% |
| Q4 2013 | $351,000 | – | 60,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 7,500,000 | $34,800,000 | 2.37% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,983,710 | $32,404,000 | 1.08% |
| DAFNA Capital Management LLC | 189,000 | $877,000 | 0.74% |
| Lyons Wealth Management, LLC. | 56,665 | $264,000 | 0.30% |
| Telemetry Investments, L.L.C. | 110,000 | $510,000 | 0.23% |
| Callan Capital, LLC | 232,000 | $1,076,000 | 0.23% |
| OXFORD ASSET MANAGEMENT LLP | 968,446 | $4,494,000 | 0.12% |
| FEDERATED HERMES, INC. | 5,641,200 | $26,175,000 | 0.08% |
| HRT FINANCIAL LP | 31,973 | $148,000 | 0.07% |
| WELLINGTON MANAGEMENT GROUP LLP | 33,885,551 | $157,230,000 | 0.04% |